NEWSLETTER June 2018 to advance education and research in the science of www.bap.org.uk psychopharmacology for the public benefit INSIDE 1–2 2018 Lifetime Achievement Award 2–7 2018 BAP Elections 7 BAP in vivo Animal Research Funding 8 BAP Psychopharmacology Awards 2018; NEW POST – BAP Assistant Director of Education 9–10 15th Computational Systems Neuroscience Conference (COSYNE), Denver 11–13 Updated Privacy Policy 13 2018 AGM Agenda 14–16 BAP Summer Meeting 2018 17 REF2021 Success; Members’ Activities 18–23 Street Drugs in the Northern Powerhouse: Perspective and Policy 23 Substance Misuse Module 24 The MRC Addiction Research Clinical Training scheme (MARC) 25–27 Education Events 2018 Lifetime Achievement Award Professor Guy Goodwin We are delighted to announce that the 2018 Lifetime Achievement Award will be presented to Professor Guy Goodwin at the Conference Dinner at the Royal British Association for Garden Hotel in Kensington on Tuesday 24 July. Psychopharmacology Guy is internationally renowned in psycho- pharmacology and his work has had a profound 36 Cambridge Place impact on both basic and clinical research particularly Hills Road in the areas of depression and bipolar disorder. Cambridge CB2 1NS Guy graduated with a 1st Class Honours degree in 01223 358 395 Animal Physiology from the University of Oxford in 1968 and completed a DPhil in Neurophysiology at Executive Officer Susan Chandler • [email protected] Oxford in 1972. His doctoral thesis included seminal work on mechanisms of kinaesthesia, the control of Assistant to the Executive Officer Lynne Harmer • [email protected] isometric contraction by muscle afferents and the role of the central command to exercise in the regulation Online Resources and Communications Developer of the cardiovascular and respiratory systems which Sarah Channing-Wright • [email protected] was published in highly cited papers in “Science” and “Brain”. Following a two year period of post-doctoral For m @BAPsych research at the Primate Centre of the University of Washington in Seattle, Guy returned to medical BritishAssociationforPsychopharmacology continued on page 2 /company/britishassociationforpsychopharmacology The British Association for Psychopharmacology is registered in England +BapOrgUk as a Private Company No 5866899. Registered Charity No 277825. continued from page 1 that correlated with memory impairment. This has supported a shift in drug development towards an training at Oxford and graduated in medicine in interest in neurogenesis as a mechanism underlying 1978. Further general clinical training and training the action of effective antidepressants and cognition as in psychiatry in Oxford and London from 1978-1983 a target for remediation in depression. Guy continues preceded Guy’s appointment as an MRC Clinical to break new ground in experimental medicine studies Training Fellow at the MRC Clinical Pharmacology and treatment trials in psychiatry and has been a Unit in the Radcliffe Infirmary in Oxford in 1983. lead investigator in clinical trials for bipolar affective Working with Richard Green and David Graeme- disorder, including the BALANCE, CEQUEL and Smith, Guy conducted a biochemical and behavioural OXTEXT studies. Guy has contributed to the systematic analysis of serotonin function at novel 5-HT receptors review of most of the important drug treatments for in the brain and how these actions are modified by bipolar disorder and in collaboration wrote widely cited antidepressants and lithium. This work has had a guidelines supporting evidence-based treatment. significant and enduring impact on the search for novel antidepressants. Subsequently, in 1986 Guy National and International recognition of Guy’s took up the position of MRC Clinical Scientist and talents is evidenced by his election as a Fellow of the Honorary Consultant Psychiatrist at the University American College of Neuropsychopharmacology of Edinburgh and in 1995 became Professor of and as a Fellow of the Academy of Medical Sciences Psychiatry. After 10 years “north of the border “ in addition to numerous prestigious awards and Guy returned to Oxford in 1996 to become the W.A. prizes in Psychopharmacology. Guy is also currently Handley Professor and Head of the Department of the Past-President of the European College of Psychiatry at the Warneford Hospital for the next Neuropsychopharmacology. Guy has been a driving 15 years. He retired from the university earlier this force in the BAP for more than 25 years, first year, to be free to take on new professional interests being elected as a member of Council in 1993 and which include the re-medicalization of psilocybin subsequently becoming President from 2002 to 2004. and improving how mood disorders are currently Guy has been and continues to be a regular attendee treated in primary and secondary care. and contributor to BAP meetings and BAP guidelines and is a longstanding member of the Editorial Board Over the past 35 years Guy has significantly impacted of the Journal of Psychopharmacology. Warmest research and clinical practice in the areas of bipolar congratulations to Guy on behalf of the BAP Council. disorder and depression and has conducted innovative clinical studies that often combine cognitive testing Colin Dourish and neuroimaging. In particular, Guy initiated studies of the processing of facial expressions of emotion and memory which have transformed our understanding 2018 Election for BAP Officers of how antidepressants work at a psychological level. This work has facilitated the discovery of novel and Council Members antidepressants and led to the development of an The following vacancies will arise on BAP Council in innovative method to rapidly identify the optimal July: antidepressant therapy for individual patients being treated for depression in primary care. Guy’s President-elect contributions to British psychopharmacology are Professor Allan Young will become President many and varied and he has trained numerous talented clinicians and scientists many of whom have gone on Two Elected Council Member posts to have very successful careers in their own right. (Post 3) Professor Carmine Pariante will retire Guy has published more than 500 papers with an h index of over 100. Of particular significance is his discovery of (Post 4) Dr Rachel Upthegrove has held this post as a the functional and structural brain changes associated casual vacancy since 2016 with severe depression. The findings in chronic One nomination was received for the post of depression showed a loss of tissue in hippocampus President Elect, so Professor Kevin Fone will be elected unopposed. Read Kevin’s statement below. 2 June 2018 Voting is online via the website only and will close Council Meetings: on MONDAY 2 JULY. The results will be announced at the Annual General Meeting on Monday 23 July in Three each year: March (London, 10:30–15:30), July London, in association with the Summer Meeting at (Sunday morning in association with the Summer Imperial College. Meeting), October/November (London, 10:30–15:30). The BAP aims to represent the interests of all Expenses: psychopharmacologists. Council asks Members to bear Council Members do not receive payment for this in mind when voting, to ensure a balance of expertise. anything they do for the BAP. BAP will reimburse Please refer to the BAP Equality and Diversity Statement standard travel expenses and hotel accommodation www.bap.org.uk/equality.php if Council members are unable to cover these from Council Members serve a 4-year term. an alternative source. Current Officers and Council See website for biographies www.bap.org.uk/council ELECTED OFFICERS ELECTED COUNCIL MEMBERS Professor Jo Neill Dr Michael Browning (Post 1) President Dr Tom Freeman Professor Allan Young (Post 2) President-Elect Dr Carmine Pariante (Post 3) Professor Paul Harrison Dr Rachel Upthegrove Past-President (Post 4) (filling a casual vacancy until July 2018) Dr Elizabeth Tunbridge Professor Ciara McCabe Honorary Treasurer (Post 5) Vacant until July 2019 due to Dr Talbot Dr Mitul Mehta moving to General Secretary post Meetings Secretary (Post 6) Dr Paul Stokes Dr Peter Talbot (Post 7) Honorary General Secretary Dr Angela Roberts Professor Jeremy Hall (Post 8) Secretary for Clinical External Affairs OTHER VOTING MEMBERS OF COUNCIL Dr Sarah Bailey Secretary for Non-Clinical External Affairs Jonas Eberhard June 2018 3 Candidates’ Biographies and Statements Kevin Fone Kevin has been extremely fortunate and grateful to have received collaborative funding from an array of University of Nottingham pharmaceutical companies and Research Councils. Proposer: Professor David Nutt He has published over 130 peer-reviewed articles, Seconder: Professor Nicol Ferrier supervised 40 postgraduate students, served on several editorial boards, is a Fellow of the British Kevin Fone has Pharmacological Society and currently President of been Professor of the International Society for Serotonin Research. Neuroscience in the School of Life Sciences at the University of Michael Bloomfield Nottingham since University College London 2006. He completed his BSc and PhD in Proposer: Professor Oliver Howes Pharmacology at Seconder: Professor Val Curran the University of I have recently been Liverpool before starting an MRC funded post- appointed as a UCL doctoral research position in Nottingham, where Excellence Fellow he has remained since 1984 and helped establish and will be working a successful Neuroscience undergraduate degree. clinically with His research focus has been